Literature DB >> 15473510

The development and psychometric evaluation of the Motivation and Energy Inventory (MEI).

S E Fehnel1, C M Bann, S L Hogue, W J Kwong, S S Mahajan.   

Abstract

Because depressed patients commonly experience reductions in motivation and energy, both as symptoms of their disorder and as side effects of pharmacotherapy, it is important to identify interventions that can restore their vitality. The Motivation and Energy Inventory (MEI) was recently developed to facilitate the evaluation of such efforts both in depression research, as well as in other therapeutic areas where vitality is an important issue. The constructs addressed by the MEI were identified through a combination of literature review, consultation with experts, and patient focus groups. Potential problems identified during cognitive testing and addressed in subsequent revisions related to the instructions, reference period, response scale sizes, and response scale labels, as well as a number of item-specific issues. Most recently, the data from two randomized, placebo-controlled clinical trials were utilized to evaluate the psychometric properties of the new questionnaire. In general, the data collected during the first and second trial were used for exploratory and confirmatory analysis, respectively. Consistent with the measurement model of the MEI, the psychometric results confirm that the instrument has three factors generally addressing physical energy, mental energy, and social motivation. Furthermore, these results provide evidence for the internal consistency, construct validity, and responsiveness of all three MEI subscales. Additional work is currently underway to examine test-retest reliability and establish minimal clinically important difference values for the MEI subscales.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15473510     DOI: 10.1023/B:QURE.0000037502.64077.4d

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  24 in total

Review 1.  Methods for assessing responsiveness: a critical review and recommendations.

Authors:  J A Husted; R J Cook; V T Farewell; D D Gladman
Journal:  J Clin Epidemiol       Date:  2000-05       Impact factor: 6.437

2.  Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders.

Authors:  S Wessely; R Powell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

3.  The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer.

Authors:  B F Piper; S L Dibble; M J Dodd; M C Weiss; R E Slaughter; S M Paul
Journal:  Oncol Nurs Forum       Date:  1998-05       Impact factor: 2.172

4.  The QLDS: a scale for the measurement of quality of life in depression.

Authors:  S M Hunt; S P McKenna
Journal:  Health Policy       Date:  1992-10       Impact factor: 2.980

5.  Development of a fatigue scale.

Authors:  T Chalder; G Berelowitz; T Pawlikowska; L Watts; S Wessely; D Wright; E P Wallace
Journal:  J Psychosom Res       Date:  1993       Impact factor: 3.006

6.  The Nottingham Health Profile: subjective health status and medical consultations.

Authors:  S M Hunt; S P McKenna; J McEwen; J Williams; E Papp
Journal:  Soc Sci Med A       Date:  1981-05

7.  Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

Authors:  S B Yellen; D F Cella; K Webster; C Blendowski; E Kaplan
Journal:  J Pain Symptom Manage       Date:  1997-02       Impact factor: 3.612

Review 8.  Epidemiology of affective disorders. A reexamination and future directions.

Authors:  J H Boyd; M M Weissman
Journal:  Arch Gen Psychiatry       Date:  1981-09

9.  The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

Authors:  E M Smets; B Garssen; B Bonke; J C De Haes
Journal:  J Psychosom Res       Date:  1995-04       Impact factor: 3.006

10.  A brief mental fatigue questionnaire.

Authors:  R P Bentall; G C Wood; T Marrinan; C Deans; R H Edwards
Journal:  Br J Clin Psychol       Date:  1993-09
View more
  16 in total

1.  Accuracy of audio computer-assisted self-interviewing (ACASI) and self-administered questionnaires for the assessment of sexual behavior.

Authors:  Dianne Morrison-Beedy; Michael P Carey; Xin Tu
Journal:  AIDS Behav       Date:  2006-09

2.  Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia.

Authors:  James Signorovitch; Andres Brainsky; Kelly M Grotzinger
Journal:  Qual Life Res       Date:  2011-05-01       Impact factor: 4.147

3.  Walking energetics, fatigability, and fatigue in older adults: the study of energy and aging pilot.

Authors:  Catherine A Richardson; Nancy W Glynn; Luigi G Ferrucci; Dawn C Mackey
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-09-04       Impact factor: 6.053

4.  Sleep in Schizophrenia: Exploring Subjective Experiences of Sleep Problems, and Implications for Treatment.

Authors:  Vivian W Chiu; Melissa Ree; Aleksandar Janca; Flavie Waters
Journal:  Psychiatr Q       Date:  2016-12

5.  Exercise is an effective treatment for positive valence symptoms in major depression.

Authors:  Marisa Toups; Thomas Carmody; Tracy Greer; Chad Rethorst; Bruce Grannemann; Madhukar H Trivedi
Journal:  J Affect Disord       Date:  2016-10-15       Impact factor: 4.839

6.  Clinical and Preclinical Assessments of Anhedonia in Psychiatric Disorders.

Authors:  Shijing Wang; Francesco Leri; Sakina J Rizvi
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 7.  Assessing anhedonia in depression: Potentials and pitfalls.

Authors:  Sakina J Rizvi; Diego A Pizzagalli; Beth A Sproule; Sidney H Kennedy
Journal:  Neurosci Biobehav Rev       Date:  2016-03-06       Impact factor: 8.989

Review 8.  Fatigue in Patients with Major Depressive Disorder: Prevalence, Burden and Pharmacological Approaches to Management.

Authors:  Helia Ghanean; Amanda K Ceniti; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

9.  Safety and efficacy of bupropion extended release in treating a community sample of Hispanic and african american adults with major depressive disorder: an open-label study.

Authors:  Paul K Gross; Rosemary Nourse; Thomas E Wasser; Deo Bukenya
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

10.  A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder.

Authors:  Angelo Sambunaris; Anjana Bose; Carl P Gommoll; Changzheng Chen; William M Greenberg; David V Sheehan
Journal:  J Clin Psychopharmacol       Date:  2014-02       Impact factor: 3.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.